← Open Payments lookup

XIOMARA PORRAS: Open Payments

NPI 1245581883 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,152 in 101 payments from 10 companies in 2025. Trend: 2023 $2,855 · 2024 $2,848 · 2025 $3,152

Food & beverage: $3,042Education: $109
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc23$778
Alkermes, Inc.18$456
Otsuka America Pharmaceutical, Inc.12$453
Axsome Therapeutics, Inc.6$395
Teva Pharmaceuticals USA, Inc.12$346
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$237
Supernus Pharmaceuticals, Inc.4$207
ABBVIE INC.13$171
Neurocrine BioSciences, Inc.4$92
GlaxoSmithKline, LLC.1$17

Products named: INVEGA SUSTENNA, SPRAVATO, ARISTADA, CAPLYTA, REXULTI, Symbravo, Qelbree, Auvelity.

Industry payments across OK — which companies pay providers there.